Menu
Sign In Pricing Add Podcast

Huberman Lab

Dr. Peter Attia: Supplements for Longevity & Their Efficacy

6161.847 - 6190.046 Dr. Peter Attia

But I think Joan Manick and Lloyd Clickstein, when they published that paper in 2014 using everolimus, where they took a group of 65-year-olds and randomized them to either a placebo or different doses and dosing schedules of everolimus, found an enhanced immunity in response to an influenza vaccine, which again was, for me, that was the turning point. That's when rapamycin went from

0
💬 0

Comments

There are no comments yet.

Log in to comment.